Authors

• Yosuke Murata
• Takuto Nosaka (ORCID: https://orcid.org/0000-0002-1929-7305)
• Tomoko Tanaka (ORCID: https://orcid.org/0000-0002-3826-3653)
• Masahiro Ohtani (ORCID: https://orcid.org/0000-0003-2408-5785)
• Tetsuya Tsujikawa (ORCID: https://orcid.org/0000-0002-8980-1044)
• Yoshikazu Maeda (ORCID: https://orcid.org/0000-0002-3040-5549)
• Ryotaro Sugata
• Hiroyasu Tamamura
• Yu Akazawa (ORCID: https://orcid.org/0000-0002-8030-7373)
• Yasunari Nakamoto (ORCID: https://orcid.org/0000-0002-3160-3555)
• Kazuto Takahashi (ORCID: https://orcid.org/0000-0003-4952-8714)
• Yoshitaka Sato (ORCID: https://orcid.org/0000-0002-8143-2176)
• Tatsushi Naito (ORCID: https://orcid.org/0000-0001-5472-8193)
• Kenji Takata

Institutions

• University of Fukui (JP)
• Fukui University of Technology (JP)
• Fukui Prefectural Hospital (JP)

Publication Details

Journal

Cancers

Published

2025-08-30

DOI

https://doi.org/10.3390/cancers17172849

Primary Topic

Hepatocellular Carcinoma Treatment and Prognosis

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Japan Agency for Medical Research and Development
• Japan Society for the Promotion of Science